Patents by Inventor Emma Aneheim

Emma Aneheim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Automatic process platform for the production of astatine-211 [At-211]-radiopharmaceuticals
    Patent number: 11851383
    Abstract: A system and method for automatic production of astatine-211 labeled molecules is described. The invention represents a significant advantage in the preparation of At-211 radiopharmaceuticals including better reproducibility, reduced production time and increased radiation safety. The invention also enables routine automatic synthesis of radiopharmaceuticals in a clinical setting, in conjunction or at short distance from a cyclotron unit capable of producing the radionuclide.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: December 26, 2023
    Assignee: Alpha Therapy Solutions AB
    Inventors: Sture Lindegren, Emma Aneheim
  • AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [ AT 211] RADIOPHARMACEUTICALS
    Publication number: 20210139389
    Abstract: A system and method for automatic production of astatine-211 labeled molecules is described. The invention represents a significant advantage in the preparation of At-211 radiopharmaceuticals including better reproducibility, reduced production time and increased radiation safety. The invention also enables routine automatic synthesis of radiopharmaceuticals in a clinical setting, in conjunction or at short distance from a cyclotron unit capable of producing the radionuclide.
    Type: Application
    Filed: October 1, 2020
    Publication date: May 13, 2021
    Inventors: Sture Lindegren, Emma Aneheim
  • Automatic process platform for the production of astatine-211 [At 211] radiopharmaceuticals
    Patent number: 10829423
    Abstract: A system and method for automatic production of astatine-211 labeled molecules is described. The invention represents a significant advantage in the preparation of At-211 radiopharmaceuticals including better reproducibility, reduced production time and increased radiation safety. The invention also enables routine automatic synthesis of radiopharmaceuticals in a clinical setting, in conjunction or at short distance from a cyclotron unit capable of producing the radionuclide.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: November 10, 2020
    Assignee: Alpha Therapy Solutions AB
    Inventors: Sture Lindegren, Emma Aneheim
  • AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS
    Publication number: 20180215680
    Abstract: A system and method for automatic production of astatine-211 labeled molecules is described. The invention represents a significant advantage in the preparation of At-211 radiopharmaceuticals including better reproducibility, reduced production time and increased radiation safety. The invention also enables routine automatic synthesis of radiopharmaceuticals in a clinical setting, in conjunction or at short distance from a cyclotron unit capable of producing the radionuclide.
    Type: Application
    Filed: June 17, 2015
    Publication date: August 2, 2018
    Inventors: Sture Lindegren, Emma Aneheim